<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Tissue macrophage accumulation is thought to induce <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> during <z:hpo ids='HP_0001513'>obesity</z:hpo> and stimulate the progression of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Monocyte chemoattractant protein-1 (<z:chebi fb="17" ids="50099">MCP</z:chebi>-1) is a potent stimulator of macrophage recruitment </plain></SENT>
<SENT sid="2" pm="."><plain>It is increased in adipose tissue during <z:hpo ids='HP_0001513'>obesity</z:hpo> and in diabetic kidneys, suggesting that <z:mp ids='MP_0001845'>inflammation</z:mp> of these tissues may be <z:chebi fb="17" ids="50099">MCP</z:chebi>-1-dependent </plain></SENT>
<SENT sid="3" pm="."><plain>Based on these findings, the aim of this study was to examine whether a deficiency in <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 would alter the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and its renal complications </plain></SENT>
<SENT sid="4" pm="."><plain>MATERIALS AND METHODS: The role of <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 in the progression of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and its associated renal injury was assessed in <z:mp ids='MP_0001261'>obese</z:mp> db/db mice that were deficient in the gene encoding <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 (Ccl2) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The incidence and development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were similar in Ccl2(+/+) and Ccl2(-/-) db/db mice between 8 and 32 weeks of age </plain></SENT>
<SENT sid="6" pm="."><plain>Body mass, <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>, <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e>, <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin tolerance, plasma triacylglycerol and serum NEFA were not different between these strains </plain></SENT>
<SENT sid="7" pm="."><plain>Pathological changes in epididymal adipose tissue, including increases in macrophage accumulation and Tnfa <z:chebi fb="2" ids="33699">mRNA</z:chebi> and reductions in Adipoq <z:chebi fb="2" ids="33699">mRNA</z:chebi>, were unaffected by the absence of <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, kidney macrophage accumulation and the progression of diabetic renal injury (<z:mp ids='MP_0002871'>albuminuria</z:mp>, histopathology, <z:mp ids='MP_0003985'>renal fibrosis</z:mp>) were substantially reduced in Ccl2(-/-) compared with Ccl2(+/+) db/db mice with equivalent <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: Our study demonstrates that <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 promotes type 2 diabetic renal injury but does not influence the development of <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in db/db mice </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="17" ids="50099">MCP</z:chebi>-1 plays a critical role in <z:mp ids='MP_0001845'>inflammation</z:mp> of the kidney, but not adipose tissue, during the progression of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>